<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:27:38Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6703851" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6703851</identifier>
        <datestamp>2019-09-04</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6703851</article-id>
              <article-id pub-id-type="pmcid">PMC6703851</article-id>
              <article-id pub-id-type="pmc-uid">6703851</article-id>
              <article-id pub-id-type="pmid">31433823</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0221061</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-19-10554</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Developmental Biology</subject>
                    <subj-group>
                      <subject>Fibrosis</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Blood Pressure</subject>
                      <subj-group>
                        <subject>Hypertension</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Chemistry</subject>
                    <subj-group>
                      <subject>Chemical Elements</subject>
                      <subj-group>
                        <subject>Gadolinium</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Cardiology</subject>
                    <subj-group>
                      <subject>Ejection Fraction</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Diagnostic Medicine</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Physics</subject>
                    <subj-group>
                      <subject>Condensed Matter Physics</subject>
                      <subj-group>
                        <subject>Magnetism</subject>
                        <subj-group>
                          <subject>Magnetic Resonance</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Cardiovascular Medicine</subject>
                    <subj-group>
                      <subject>Cardiovascular Diseases</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Cardiology</subject>
                    <subj-group>
                      <subject>Cardiomyopathies</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy</article-title>
                <alt-title alt-title-type="running-head">CMR-FT strain for LV hypertrophy differentiation</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4744-9166</contrib-id>
                  <name>
                    <surname>Neisius</surname>
                    <given-names>Ulf</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Visualization</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4844-6517</contrib-id>
                  <name>
                    <surname>Myerson</surname>
                    <given-names>Lana</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fahmy</surname>
                    <given-names>Ahmed S.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Software</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nakamori</surname>
                    <given-names>Shiro</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>El-Rewaidy</surname>
                    <given-names>Hossam</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Joshi</surname>
                    <given-names>Gargi</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Duan</surname>
                    <given-names>Chong</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Manning</surname>
                    <given-names>Warren J.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nezafat</surname>
                    <given-names>Reza</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Funding acquisition</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Coelho-Filho</surname>
                    <given-names>Otavio Rizzi</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Faculty of Medical Science - State University of Campinas, BRAZIL</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>rnezafat@bidmc.harvard.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>21</day>
                <month>8</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2019</year>
              </pub-date>
              <volume>14</volume>
              <issue>8</issue>
              <elocation-id>e0221061</elocation-id>
              <history>
                <date date-type="received">
                  <day>18</day>
                  <month>4</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>29</day>
                  <month>7</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2019 Neisius et al</copyright-statement>
                <copyright-year>2019</copyright-year>
                <copyright-holder>Neisius et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0221061.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>Hypertensive heart disease (HHD) and hypertrophic cardiomyopathy (HCM) are both associated with an increased left ventricular (LV) wall thickness. Whilst LV ejection fraction is frequently normal in both, LV strain assessment could differentiate between the diseases. We sought to establish if cardiovascular magnetic resonance myocardial feature tracking (CMR-FT), an emerging method allowing accurate assessment of myocardial deformation, differentiates between both diseases. Additionally, CMR assessment of fibrosis and LV hypertrophy allowed association analyses and comparison of diagnostic capacities.</p>
                </sec>
                <sec id="sec002">
                  <title>Methods</title>
                  <p>Two-hundred twenty-four consecutive subjects (53 HHD, 107 HCM, and 64 controls) underwent 1.5T CMR including native myocardial T<sub>1</sub> mapping and late gadolinium enhancement (LGE). Global longitudinal strain (GLS) was assessed by CMR-FT (CVi42, Circle Cardiovascular Imaging Inc.).</p>
                </sec>
                <sec id="sec003">
                  <title>Results</title>
                  <p>GLS was significantly higher in HCM patients (-14.7±3.8 vs. -16.5±3.3% [HHD], P = 0.004; or vs. -17.2±2.0% [controls], P&lt;0.001). GLS was associated with LV mass index (HHD, R = 0.419, P = 0.002; HCM, R = 0.429, P&lt;0.001), and LV ejection fraction (HHD, R = -0.493, P = 0.002; HCM, R = -0.329, P&lt;0.001). In HCM patients, GLS was also associated with global native T<sub>1</sub> (R = 0.282, P = 0.003), and LGE volume (ρ = 0.380, P&lt;0.001). Discrimination between HHD and HCM by GLS (c = 0.639, 95% confidence interval [CI] 0.550–0.729) was similar to LV mass index (c = 0.643, 95% CI 0.556–0.731), global myocardial native T<sub>1</sub> (c = 0.718, 95% CI 0.638–0.799), and LGE volume (c = 0.680, 95% CI 0.585–0.775).</p>
                </sec>
                <sec id="sec004">
                  <title>Conclusion</title>
                  <p>CMR-FT GLS differentiates between HHD and HCM. In HCM patients GLS is associated with myocardial fibrosis. The discriminatory capacity of CMR-FT GLS is similar to LV hypertrophy and fibrosis imaging markers.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1R01HL129185-01</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Nezafat</surname>
                      <given-names>Reza</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1R01HL129157</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Nezafat</surname>
                      <given-names>Reza</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1R01HL127015</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Nezafat</surname>
                      <given-names>Reza</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000968</institution-id>
                      <institution>American Heart Association</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>15EIA22710040</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Nezafat</surname>
                      <given-names>Reza</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>Dr. Nezafat receives grant funding by the National Institutes of Health 1R01HL129185-01, 1R01HL129157, and 1R01HL127015 (Bethesda, MD, USA); and the American Heart Association (AHA) 15EIA22710040 (Waltham, MA, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="4"/>
                <page-count count="18"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are within the paper and its supporting information files.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are within the paper and its supporting information files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec005">
              <title>Introduction</title>
              <p>Considering an aging population with an increased prevalence of hypertension, the differential diagnosis for patients with increased left ventricular (LV) wall thickness (LVWT) represents a diagnostic challenge often encountered in cardiovascular imaging laboratories. Next to hypertensive heart disease (HHD) [<xref rid="pone.0221061.ref001" ref-type="bibr">1</xref>], hypertrophic cardiomyopathy (HCM) with a frequency of 1/500 in the general population [<xref rid="pone.0221061.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0221061.ref003" ref-type="bibr">3</xref>] shares the phenotype.</p>
              <p>Until late disease stages, HHD and HCM exhibit normal systolic function by conventional measurements, such as LV ejection fraction or fractional shortening [<xref rid="pone.0221061.ref002" ref-type="bibr">2</xref>–<xref rid="pone.0221061.ref004" ref-type="bibr">4</xref>]. Yet an early decline in myocardial mechanics measured by strain analysis has been observed in both [<xref rid="pone.0221061.ref005" ref-type="bibr">5</xref>–<xref rid="pone.0221061.ref013" ref-type="bibr">13</xref>]. For instance, longitudinal strain by speckle tracking echocardiography (STE) differentiates hypertensive patients with normal cardiac function and dimensions [<xref rid="pone.0221061.ref008" ref-type="bibr">8</xref>] as well as phenotype negative genotype positive HCM [<xref rid="pone.0221061.ref014" ref-type="bibr">14</xref>] cases from controls.</p>
              <p>In hypertensive rats, diffuse subendocardial fibrosis correlates with reduced longitudinal contractility, whilst midwall fibrosis occurs only in later disease stages and correlates with a decline in circumferential strain [<xref rid="pone.0221061.ref015" ref-type="bibr">15</xref>]. Correspondingly, clinical observations showed a decline in longitudinal strain in non-hypertrophied hypertensive patients [<xref rid="pone.0221061.ref008" ref-type="bibr">8</xref>], whilst circumferential strain is only significantly reduced in hypertensive patients with left ventricular hypertrophy (LVH) [<xref rid="pone.0221061.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0221061.ref008" ref-type="bibr">8</xref>]. In HCM patients, strain attenuation is more related to myocyte disarray [<xref rid="pone.0221061.ref016" ref-type="bibr">16</xref>] rather than fibrosis. Since myocyte disarray is widely distributed including areas of normal wall thickness and typically involves &gt;20% of the myocardium [<xref rid="pone.0221061.ref017" ref-type="bibr">17</xref>], it might impact more significantly on strain measurements than pathophysiological processes in HHD.</p>
              <p>On histology, HHD and HCM patients share myocyte hypertrophy and fibrosis [<xref rid="pone.0221061.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0221061.ref019" ref-type="bibr">19</xref>]. The latter can be divided into replacement and diffuse fibrosis, which are quantifiable by cardiovascular magnetic resonance (CMR) imaging through late gadolinium enhancement (LGE) [<xref rid="pone.0221061.ref020" ref-type="bibr">20</xref>] and native myocardial T<sub>1</sub> mapping [<xref rid="pone.0221061.ref021" ref-type="bibr">21</xref>], respectively. Both have been reported to be more prominent in HCM [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>] and to be associated with a decline of regional strain measurement [<xref rid="pone.0221061.ref023" ref-type="bibr">23</xref>].</p>
              <p>Recently, CMR myocardial feature tracking (CMR-FT), a software solution similar to STE [<xref rid="pone.0221061.ref024" ref-type="bibr">24</xref>], has been introduced for high-resolution evaluation of global and regional myocardial mechanics. CMR-FT tracks the epi- and endocardial borders and has been evaluated in a wide range of cardiovascular disease [<xref rid="pone.0221061.ref024" ref-type="bibr">24</xref>]. Related to the excellent image quality of CMR, CMR-FT has an excellent intra- and interobserver agreement for longitudinal strain [<xref rid="pone.0221061.ref025" ref-type="bibr">25</xref>], as well as good agreement with STE [<xref rid="pone.0221061.ref026" ref-type="bibr">26</xref>].</p>
              <p>Considering the different pathophysiological processes in HHD and HCM and their related cardiac mechanics, we hypothesized that CMR-FT global longitudinal strain (GLS) would differentiate between diseases. We also postulated that CMR-FT strain would be associated with myocardial fibrosis and hypertrophy measurements.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec006">
              <title>Material and methods</title>
              <p>The study was approved by the Beth Israel Deaconess Medical Center’s Institutional Review Board (Protocol Number: 2001P-000793). Written consent was obtained. Two hundred and twenty-four consecutive subjects, referred for CMR at our center between July 2014 and March 2018 and meeting the criteria described below, were included in this retrospective study. The same dataset was previously used for radiomic analysis of myocardial native T<sub>1</sub> imaging to differentiate between HHD and HCM and was reported in [<xref rid="pone.0221061.ref027" ref-type="bibr">27</xref>]. In the current study we however address a different hypothesis: GLS computed by CMR-FT can discriminate between both diseases. The investigated patients groups (healthy controls, HHD and HCM patients) were defined based on established diagnostic criteria and related CMR measurements [<xref rid="pone.0221061.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0221061.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0221061.ref028" ref-type="bibr">28</xref>–<xref rid="pone.0221061.ref030" ref-type="bibr">30</xref>].</p>
              <p>Patients with HCM (n = 107) demonstrated either normal LV cavity size with maximum LVWT ≥15 mm, or LVWT above the normal range (≥12 mm) [<xref rid="pone.0221061.ref030" ref-type="bibr">30</xref>] in the context of high clinical suspicion (i.e. apical variant phenotype, HCM family history + LVWT ≥13 mm), both not explained by loading conditions [<xref rid="pone.0221061.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0221061.ref003" ref-type="bibr">3</xref>]. HHD (n = 53) was defined as increased LVWT (≥12 mm) in the presence of arterial hypertension [<xref rid="pone.0221061.ref028" ref-type="bibr">28</xref>] (i.e. systolic blood pressure ≥140 mmHg on two separate occasions, documented diagnosis of hypertension) and absence of LV cavity dilatation, severe chronic kidney disease, and cardiac disease associated with a similar magnitude of hypertrophy. All control subjects (n = 64) had normal cardiac dimensions/volumes, normal cardiac function, and absence of LGE in common and lacked a history of cardiac disease. Subjects were excluded from the study based on an established diagnosis of Anderson-Fabry disease, amyloidosis, or iron-deposition, history of ST-segment elevation myocardial infarction, evidence of inflammatory processes in the myo- or pericardium, and athletic activity with sufficient duration, intensity and frequency to explain abnormal LVWT.</p>
              <sec id="sec007">
                <title>CMR imaging and analysis</title>
                <p>CMR images were acquired with a 1.5T scanner (Achieva, Philips Healthcare, Best, The Netherlands) equipped with a 32-element cardiac coil. Breath-hold, retrospectively electrocardiogram (ECG)-gated cine, balanced steady state free-precision (bSSFP) images were recorded in the LV 2- and 4-chamber long-axis views, and a short-axis stack covering the entire LV (8-mm slices with 2-mm gaps).</p>
                <p>CMR images were interpreted using ViewForm software (Release 4, Philips Healthcare). LV and right ventricular volumes were quantified by manually tracing the end-diastolic and end-systolic endocardial contours and applying a summation of discs method. Slices at the base of LV were included if &gt;50% of the blood pool was encircled by myocardium. LV dimensions or the maximum LVWT were quantified in the short-axis view at the level of the chordae or at the slice with largest endo- to epicardial border distance, respectively. LV mass was calculated as the total myocardial volume without papillary muscles multiplied by the specific gravity of myocardial tissue (1.05 g/mL). LV mass index (LVMI) ≥81 g/m<sup>2</sup> in men and ≥62 g/m<sup>2</sup> in women [<xref rid="pone.0221061.ref029" ref-type="bibr">29</xref>] were used to defined LVH. LV end-diastolic volume index &gt;105 ml for men and &gt;96 ml for women [<xref rid="pone.0221061.ref031" ref-type="bibr">31</xref>] were used to defined LV cavity dilatation. Asymmetric or apical hypertrophy were defined as maximum LVWT ≥12 mm [<xref rid="pone.0221061.ref030" ref-type="bibr">30</xref>] with a septal to posterior free wall ratio (interventricular septum/posterior wall ratio) &gt;1.3 [<xref rid="pone.0221061.ref032" ref-type="bibr">32</xref>] or segmental hypertrophy confined to the LV apex [<xref rid="pone.0221061.ref033" ref-type="bibr">33</xref>], respectively.</p>
                <p>CMR-FT analysis was carried out using CVi42 (Circle Cardiovascular Imaging Inc. Calgary, Canada). LV endo- and epicardial borders were manually traced at end-diastole in ECG-gated bSSFP 4- and 2-chamber long-axis sequences using a point-and-click approach. The automatic border tracking algorithm of the software was applied to track image features throughout the cardiac cycle. Tracking was visually reviewed and manually corrected by border adjustment with consecutive reapplication of the algorithm if necessary. To adjust for morphological differences between the HHD and HCM cohorts, GLS was also investigated in the previously reported “equal LVWT subgroup” that was matched for LVWT, gender, LVH, and assembled with similar age, LVMI, and T<sub>1</sub> values [<xref rid="pone.0221061.ref027" ref-type="bibr">27</xref>].</p>
                <p>LV LGE images were obtained using a three dimensional (3D) phase sensitive inversion-recovery (PSIR) sequence with spectral fat saturation pre-pulses during the end-diastolic phase approximately 15 minutes after administration of 0.1 mmol/kg body weight gadobenate dimeglumine (Multihance, Bracco Diagnostics Inc., Monroe Township, New Jersey, US). LGE presence and percentage (%LGE) were measured by an experienced (level 3 trained) reader (U.N.) blinded to clinical and laboratory data using an automated LV contour and LGE area quantification algorithm [<xref rid="pone.0221061.ref034" ref-type="bibr">34</xref>]. Accurate measurements were assured by visual review of all contours. Manual epi- and endocardial contour correction and adjustment of a gray-scale threshold to correct/define areas of visually identified LGE [<xref rid="pone.0221061.ref035" ref-type="bibr">35</xref>] was conducted if necessary. %LGE was calculated by summing the area of LGE in all short-axis slices, which was expressed as a volumetric proportion of the total LV myocardium.</p>
                <p>Native myocardial T<sub>1</sub> mapping was conducted using the slice-interleaved T<sub>1</sub> mapping (STONE) sequence, which allows acquisition of 5 slices in the short-axis plane during a 90 seconds free breathing scan, as previously describe [<xref rid="pone.0221061.ref036" ref-type="bibr">36</xref>]. A 2-paramter fit model and voxel-wise curve fitting were applied to estimate individual T<sub>1</sub> maps using custom software (MedIACare, Boston, Massachusetts, US). An adaptive registration of varying contrast-weighted images enabled motion correction [<xref rid="pone.0221061.ref037" ref-type="bibr">37</xref>]. The five resulting T<sub>1</sub> maps were averaged to obtain the global native T<sub>1</sub> value. Septal T<sub>1</sub> and apical T<sub>1</sub> were calculated as the average value of segments 2, 3, 8, 9 or 13-16/17 of the American Heart Association 16/17 segment model [<xref rid="pone.0221061.ref038" ref-type="bibr">38</xref>], respectively. LGE positive areas were excluded from T<sub>1</sub> quantification.</p>
              </sec>
              <sec id="sec008">
                <title>Reproducibility</title>
                <p>CMR-FT was performed by a single investigator (U.N.). For reproducibility purposes, 20 randomly selected cases (10 HHD, 10 HCM) were reanalyzed by the same reader ≥ 4 weeks later and by a second blinded investigator (L.M.). Both were blinded to clinical information. Reproducibility of global native T<sub>1</sub> and LGE extent were tested based on 50 randomly selected cases and LGE quantification available in clinical reports (n = 26), respectively.</p>
              </sec>
              <sec id="sec009">
                <title>Statistical analysis</title>
                <p>Data were analyzed using SPSS (version 17.0; International Business Machines Corp., Armonk, New York, USA). Normality of data distribution was determined using the Kolmogorov-Smirnov test and visual inspection of Q-Q plots. The Chi-squared test, two-sample t-test or the Mann-Whitney U-test was conducted as appropriate. Correlation between variables was tested by Pearson and Spearman ρ correlation coefficients as appropriate. Univariate and multivariate logistic regression was used to test the ability of CMR measurements to discriminate between HHD and HCM. To test for independent association of CMR measurements in the context of demographic characteristics and &gt;1 maging marker multiple logistic regression analyses were conducted. Specificity, sensitivity, and discriminatory accuracy, cut-off values and area under the curve, were derived from receiver-operating characteristics (ROC) curve analyses using the Youden’s index. Areas under ROC curves were compared using the DeLong method. The intraclass correlation coefficient for a 2-way mixed- or random-effects model with absolute agreement was calculated to assess the intra- and interobserver reproducibility. Statistical significance was defined as a 2-sided P-value &lt;0.05 and was Bonferroni corrected for multiple cohort comparisons.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec010">
              <title>Results</title>
              <p>The clinical characteristics are summarized in <xref rid="pone.0221061.t001" ref-type="table">Table 1</xref>. In comparison to HCM patients, subjects with HHD were older (P = 0.012), had higher systolic and diastolic blood pressures (P&lt;0.001 for both), and a higher body surface area (P = 0.003).The HCM cohort included patients with asymmetric septal hypertrophy (n = 62, 58%), concentric hypertrophy (n = 26, 24%), and apical variant (n = 19, 18%; <xref ref-type="fig" rid="pone.0221061.g001">Fig 1</xref>) [<xref rid="pone.0221061.ref032" ref-type="bibr">32</xref>]. HCM group stratification by LV hypertrophy type is summarized in <xref ref-type="supplementary-material" rid="pone.0221061.s001">S1 Table</xref>. LGE was assessed in 164 patients (34 HHD, 97 HCM, and 33 healthy controls; <xref ref-type="supplementary-material" rid="pone.0221061.s002">S2 Table</xref>.</p>
              <fig id="pone.0221061.g001" orientation="portrait" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0221061.g001</object-id>
                <label>Fig 1</label>
                <caption>
                  <p><bold>Representative images of patients with asymmetric (A-C) and apical HCM (D-F).</bold> Depicted are 4- (A) and 2-chamber (D) PSIR images with late gadolinium enhancement (LGE) (arrows), peak systolic longitudinal strain maps superimposed on corresponding cine-images (B, E), and resulting longitudinal strain curves. Areas of large confluent LGE (A, D) and regions with significantly attenuated strain (B, E) overlap. The patient with asymmetric HCM had an indexed left ventricular (LV) mass of 83 g/m<sup>2</sup>, LGE extent of 22.8%, and a GLS of -9.8%. The patient with apical HCM had an indexed LV mass of 63 g/m<sup>2</sup>, LGE extent of 20.3%, and a GLS of -8.9%.</p>
                </caption>
                <graphic xlink:href="pone.0221061.g001"/>
              </fig>
              <table-wrap id="pone.0221061.t001" orientation="portrait" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0221061.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>Demographic data and cohort characteristics in HHD, HCM and healthy control groups.</title>
                </caption>
                <alternatives>
                  <graphic id="pone.0221061.t001g" xlink:href="pone.0221061.t001"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">HHD (n = 53)</th>
                        <th align="center" rowspan="1" colspan="1">HCM (n = 107)</th>
                        <th align="center" rowspan="1" colspan="1">Healthy Controls (n = 64)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, years</td>
                        <td align="center" rowspan="1" colspan="1">60±10</td>
                        <td align="center" rowspan="1" colspan="1">55±14<xref ref-type="table-fn" rid="t001fn004"><sup>‡</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">54±14</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Sex, male n (%)</td>
                        <td align="center" rowspan="1" colspan="1">44 (83)<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">75 (70)<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">32 (50)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Body surface area, m<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">2.1±0.2<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">2.0±0.2<xref ref-type="table-fn" rid="t001fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t001fn006"><sup>ǁ</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">1.9±0.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Systolic Blood Pressure, mmHg</td>
                        <td align="center" rowspan="1" colspan="1">134±16<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">127±18<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">123±15</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Diastolic Blood Pressure, mmHg</td>
                        <td align="center" rowspan="1" colspan="1">78±12<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">75±10<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">73±10</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Heart Rate, bpm</td>
                        <td align="center" rowspan="1" colspan="1">67±11</td>
                        <td align="center" rowspan="1" colspan="1">67±9</td>
                        <td align="center" rowspan="1" colspan="1">69±11</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">New York Heart Association, stage</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Stage II, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">9 (17)<xref ref-type="table-fn" rid="t001fn007"><sup>#</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">12 (11)<xref ref-type="table-fn" rid="t001fn007"><sup>#</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">0 (0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Stage III, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">0 (0)</td>
                        <td align="center" rowspan="1" colspan="1">3 (3)</td>
                        <td align="center" rowspan="1" colspan="1">0 (0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Caucasian, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">36 (70)</td>
                        <td align="center" rowspan="1" colspan="1">66 (62)<xref ref-type="table-fn" rid="t001fn006"><sup>ǁ</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">54 (84)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">53 (100)<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">53 (50) <xref ref-type="table-fn" rid="t001fn002">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">25 (39)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Medications, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">47 (87)<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">66 (62)<xref ref-type="table-fn" rid="t001fn002">*</xref><xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">20 (31)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    ACEI/ARB, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">31 (58)<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">30 (28)<xref ref-type="table-fn" rid="t001fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">13 (20)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Beta-Blocker, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">28 (53) <xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">39 (36) <xref ref-type="table-fn" rid="t001fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">7 (11)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Calcium Channel Blocker, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">25 (47) <xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">21 (20)<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">10 (16)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Diuretics, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">17 (32)<xref ref-type="table-fn" rid="t001fn006"><sup>ǁ</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">15 (14)<xref ref-type="table-fn" rid="t001fn003"><sup>†</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">8 (13)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Dyslipidemia, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">38 (72)<xref ref-type="table-fn" rid="t001fn006"><sup>ǁ</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">62 (60)</td>
                        <td align="center" rowspan="1" colspan="1">30 (47)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Diabetes mellitus, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">13 (25)<xref ref-type="table-fn" rid="t001fn006"><sup>ǁ</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">15 (14)<xref ref-type="table-fn" rid="t001fn006"><sup>ǁ</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">3 (5)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Serum Creatinine, mg/dl</td>
                        <td align="center" rowspan="1" colspan="1">1.1±0.3<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">1.0±0.2<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">0.8±0.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Estimated Glomerular Filtration Rate, %</td>
                        <td align="center" rowspan="1" colspan="1">73±19<xref ref-type="table-fn" rid="t001fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">80±20<xref ref-type="table-fn" rid="t001fn006"><sup>ǁ</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">92±23</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t001fn001">
                    <p>ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker.</p>
                  </fn>
                  <fn id="t001fn002">
                    <p>* P&lt;0.001 compared with HHD</p>
                  </fn>
                  <fn id="t001fn003">
                    <p>† P&lt;0.01 compared with HHD</p>
                  </fn>
                  <fn id="t001fn004">
                    <p>‡ P&lt;0.02 compared with HHD</p>
                  </fn>
                  <fn id="t001fn005">
                    <p>§ P&lt;0.001 compared with healthy controls</p>
                  </fn>
                  <fn id="t001fn006">
                    <p>ǁ P&lt;0.01 compared with healthy controls</p>
                  </fn>
                  <fn id="t001fn007">
                    <p># P&lt;0.02 compared with healthy controls</p>
                  </fn>
                  <fn id="t001fn008">
                    <p>P values were Bonferroni corrected (0.05/3) to account for multiple cohort comparisons.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>HCM in comparison to HHD patients (<xref rid="pone.0221061.t002" ref-type="table">Table 2</xref>) had an increased LV mass index (76±27 vs. 63±17 g/m<sup>2</sup>, P = 0.002), maximum LVWT (17 [15; 20] vs. 13 [12; 14] mm, P&lt;0.001), LGE volume (0.3 [0; 3.4] vs. 0 [0; 0.1] ml, P&lt;0.001) and global native T<sub>1</sub> (1097±36 vs. 1066±36 ms, P&lt;0.001). These differences remained significant after adjustment for age and body surface (<xref ref-type="supplementary-material" rid="pone.0221061.s003">S3 Table</xref>). There was no significant difference regarding LVEF and LV volumes between both cohorts.</p>
              <table-wrap id="pone.0221061.t002" orientation="portrait" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0221061.t002</object-id>
                <label>Table 2</label>
                <caption>
                  <title>Cardiovascular magnetic resonance parameters in HHD, HCM and control groups.</title>
                </caption>
                <alternatives>
                  <graphic id="pone.0221061.t002g" xlink:href="pone.0221061.t002"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="justify" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">HHD (n = 53)</th>
                        <th align="center" rowspan="1" colspan="1">HCM (n = 107)</th>
                        <th align="center" rowspan="1" colspan="1">Healthy Controls (n = 64)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Cardiac Volumes/Diameters</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LV end-diastolic volume index, mL/m<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">73±14</td>
                        <td align="center" rowspan="1" colspan="1">74±13</td>
                        <td align="center" rowspan="1" colspan="1">72±18</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LV end-systolic volume index, mL/m<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">29±10</td>
                        <td align="center" rowspan="1" colspan="1">26±8</td>
                        <td align="center" rowspan="1" colspan="1">28±7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    RV end-diastolic volume index, mL/m<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">71±16</td>
                        <td align="center" rowspan="1" colspan="1">66±13<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">77±15</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    RV end-systolic volume index, mL/m<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">28±11</td>
                        <td align="center" rowspan="1" colspan="1">24±8<xref ref-type="table-fn" rid="t002fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">32±9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">LV function</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LV ejection fraction, %</td>
                        <td align="center" rowspan="1" colspan="1">63±8</td>
                        <td align="center" rowspan="1" colspan="1">65±6<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">62±5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Global longitudinal strain, %</td>
                        <td align="center" rowspan="1" colspan="1">-16.5±3.3</td>
                        <td align="center" rowspan="1" colspan="1">-14.7±3.8<xref ref-type="table-fn" rid="t002fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">-17.2±2.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    4 Chamber longitudinal strain, %</td>
                        <td align="center" rowspan="1" colspan="1">-16.3±3.3</td>
                        <td align="center" rowspan="1" colspan="1">-14.3±4.0<xref ref-type="table-fn" rid="t002fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">-17.0±2.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2 Chamber longitudinal strain, %</td>
                        <td align="center" rowspan="1" colspan="1">-16.6±3.6</td>
                        <td align="center" rowspan="1" colspan="1">-15.1±4.2<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">-17.3±2.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">LV hypertrophy, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">11 (21)<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">48 (45)<xref ref-type="table-fn" rid="t002fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">0 (0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LV mass index, g/m<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">63±17<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">76±27<xref ref-type="table-fn" rid="t002fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">45±11</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LV anteroseptal wall thickness, mm</td>
                        <td align="center" rowspan="1" colspan="1">12 [12;13]<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">15 [11;17]<xref ref-type="table-fn" rid="t002fn002">*</xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">8 [7;9]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LV inferoseptal wall thickness, mm</td>
                        <td align="center" rowspan="1" colspan="1">9 [8;12]<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">9 [8;11]<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">7 [6;7]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LV wall asymmetry, n (%)[<xref rid="pone.0221061.ref032" ref-type="bibr">32</xref>]</td>
                        <td align="center" rowspan="1" colspan="1">13 (25)</td>
                        <td align="center" rowspan="1" colspan="1">55 (51)<xref ref-type="table-fn" rid="t002fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">9 (14)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Maximum LVWT, mm</td>
                        <td align="center" rowspan="1" colspan="1">13 [12;14]<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">17 [15;20]<xref ref-type="table-fn" rid="t002fn002">*</xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">8 [7;10]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Fibrosis markers</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LGE, n (%)</td>
                        <td align="center" rowspan="1" colspan="1">9 (26)<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">57 (58)<xref ref-type="table-fn" rid="t002fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">0 (0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    LGE volume, ml</td>
                        <td align="center" rowspan="1" colspan="1">0 [0;0.1]<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">0.3 [0;3.4]<xref ref-type="table-fn" rid="t002fn002">*</xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">0 [0;0]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Percent LGE, %</td>
                        <td align="center" rowspan="1" colspan="1">0 [0;0.1]<xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">0.2 [0;1.8] <xref ref-type="table-fn" rid="t002fn003"><sup>†</sup></xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">0 [0;0]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Global native T<sub>1</sub>, ms</td>
                        <td align="center" rowspan="1" colspan="1">1073±25</td>
                        <td align="center" rowspan="1" colspan="1">1097±36<xref ref-type="table-fn" rid="t002fn002">*</xref><xref ref-type="table-fn" rid="t002fn006"><sup>ǁ</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">1079±32</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Septal native T<sub>1</sub>, ms</td>
                        <td align="center" rowspan="1" colspan="1">1066±36</td>
                        <td align="center" rowspan="1" colspan="1">1099±41<xref ref-type="table-fn" rid="t002fn002">*</xref><xref ref-type="table-fn" rid="t002fn005"><sup>§</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">1070±35</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t002fn001">
                    <p>LGE, late gadolinium enhancement; LV, left ventricular; LVWT, LV wall thickness; RV, right ventricular.</p>
                  </fn>
                  <fn id="t002fn002">
                    <p>* P&lt;0.001 compared with HHD</p>
                  </fn>
                  <fn id="t002fn003">
                    <p>† P&lt;0.01 compared with HHD</p>
                  </fn>
                  <fn id="t002fn004">
                    <p>‡ P&lt;0.02 compared with HHD</p>
                  </fn>
                  <fn id="t002fn005">
                    <p>§ P&lt;0.001 compared with healthy controls</p>
                  </fn>
                  <fn id="t002fn006">
                    <p>ǁ P&lt;0.01 compared with healthy controls</p>
                  </fn>
                  <fn id="t002fn007">
                    <p># P&lt;0.02 compared with healthy controls</p>
                  </fn>
                  <fn id="t002fn008">
                    <p>P values were Bonferroni corrected (0.05/3) to account for multiple cohort comparisons.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="sec011">
                <title>Group comparison for global longitudinal strain</title>
                <p>Global longitudinal strain (GLS) was significantly higher in HCM compared to HHD patients (<xref rid="pone.0221061.t002" ref-type="table">Table 2</xref>; P = 0.004). This difference remained significant after adjustment for age and body surface area (<xref ref-type="supplementary-material" rid="pone.0221061.s003">S3 Table</xref>). The HHD to HCM differentiation was predominantly supported by patients with milder disease, as GLS was significantly different in subgroup analysis of patients with increased LVWT but without the LV mass index beyond the gender specific cut-off for LVH [<xref rid="pone.0221061.ref029" ref-type="bibr">29</xref>] (HHD<sub>LVH-</sub> vs. HCM<sub>LVH-</sub>, GLS: -17.2±2.8 vs. -15.9±3.3%, P = 0.044), whilst it was not in the subgroup with LVH (HHD<sub>LVH+</sub> vs. HCM<sub>LVH+</sub>, GLS (%):-13.8±3.8 vs. -13.2±3.8%, P = 0.653; <xref ref-type="fig" rid="pone.0221061.g002">Fig 2</xref>). We observed a difference in GLS between controls and HCM, HCM<sub>LVH-</sub> or HHD<sub>LVH+</sub> patients (P&lt;0.001, P = 0.017, and P = 0.015, respectively). Comparisons of LV mass index in each subgroup showed no significant difference between HHD and HCM (HHD<sub>LVH-</sub> vs. HCM<sub>LVH-</sub>, LV mass index: 56.8±11.4 vs. 58.4±12.9 g/m<sup>2</sup>, P = 0.503; HHD<sub>LVH+</sub> vs. HCM<sub>LVH+</sub>, LV mass index: 89.0 [87.0; 92.0] vs. 91.8 [82.4; 105.8] g/m<sup>2</sup>, P = 0.414). The GLS difference between LVH+ and LVH- patients was significant for both disease (HHD, P = 0.015; HCM, P&lt;0.001). GLS was significantly higher in the LGE positive HHD cohort (-13.8±3.8 vs. -17.2±2.8, P = 0.015), as well as the LGE positive HCM cohort (-13.4±3.6 vs. -16.2±3.6%, P&lt;0.001). The maximum LVWT and prevalence of LVH were significantly greater in HHD and HCM patients in whom LGE was detected by CMR (P&lt;0.05). GLS was different between concentric (-16.4±4.1%) and apical HCM (-13.3±3.9%, P = 0.015), but not in the comparison of asymmetric (-14.4±3.4%) with concentric or apical HCM after adjustment for multiple cohort comparison (P = 0.042 and P = 0.255, respectively). In the “equal LV wall thickness subgroup” [<xref rid="pone.0221061.ref027" ref-type="bibr">27</xref>] GLS did not differentiate between patients with HHD and HCM (P = 0.172, <xref ref-type="supplementary-material" rid="pone.0221061.s004">S4 Table</xref>).</p>
                <fig id="pone.0221061.g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0221061.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Presence of left ventricular hypertrophy (LVH) and discrimination between hypertensive heart disease (HHD) and hypertrophic cardiomyopathy (HCM).</title>
                    <p>Box plots for cardiovascular magnetic resonance myocardial feature tracking (CMR-FT) global longitudinal strain (GLS) in HHD (blue), HCM (green), and controls (beige). Groups were split according to presence (LVH+, dark color) or absence (LVH-, light color) of left ventricular hypertrophy (LVH) defined according to the gender specific cut-off of LV mass index [<xref rid="pone.0221061.ref029" ref-type="bibr">29</xref>]. Illustrated is the influence of LVH on disease discrimination: GLS differentiates between HHD and HCM in LVH- patients, whilst it does not in LVH+ patients.</p>
                  </caption>
                  <graphic xlink:href="pone.0221061.g002"/>
                </fig>
              </sec>
              <sec id="sec012">
                <title>Relationship analysis of global longitudinal strain</title>
                <p>In HCM patients, GLS was associated with LV end-diastolic volume, LV ejection fraction, LV hypertrophy markers, global native myocardial T<sub>1</sub>, and LGE volume (P&lt;0.05; <xref rid="pone.0221061.t003" ref-type="table">Table 3</xref>, <xref ref-type="fig" rid="pone.0221061.g003">Fig 3</xref>). When focusing on HCM patients with LGE, the association between GLS and LGE volume was however not significant (P = 0.157). In HHD patients, GLS was only associated with LV end-diastolic volume, LV ejection fraction and LV mass index (<xref rid="pone.0221061.t003" ref-type="table">Table 3</xref>).</p>
                <fig id="pone.0221061.g003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0221061.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>Associations of GLS, LV hypertrophy and fibrosis.</title>
                    <p>Scatter plots for CMR-FT GLS and variables related to the extent of left ventricular hypertrophy and myocardial fibrosis in HCM patients. Lines indicate the best-fit line and 95% confidence interval for the mean.</p>
                  </caption>
                  <graphic xlink:href="pone.0221061.g003"/>
                </fig>
                <table-wrap id="pone.0221061.t003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0221061.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Relationship between GLS and CMR measurements in HHD, HCM, and control groups.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0221061.t003g" xlink:href="pone.0221061.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="justify" rowspan="1" colspan="1"/>
                          <th align="center" colspan="2" rowspan="1">HHD</th>
                          <th align="center" colspan="2" rowspan="1">HCM</th>
                          <th align="center" colspan="2" rowspan="1">Healthy Controls</th>
                        </tr>
                        <tr>
                          <th align="justify" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">R/ρ</th>
                          <th align="center" rowspan="1" colspan="1">P-value</th>
                          <th align="center" rowspan="1" colspan="1">R/ρ</th>
                          <th align="center" rowspan="1" colspan="1">P-value</th>
                          <th align="center" rowspan="1" colspan="1">R/ρ</th>
                          <th align="center" rowspan="1" colspan="1">P-value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LV end-diastolic volume index, mL/m<sup>2</sup></td>
                          <td align="center" rowspan="1" colspan="1">0.182</td>
                          <td align="center" rowspan="1" colspan="1">0.193</td>
                          <td align="center" rowspan="1" colspan="1">0.152</td>
                          <td align="center" rowspan="1" colspan="1">0.117</td>
                          <td align="center" rowspan="1" colspan="1">0.329</td>
                          <td align="center" rowspan="1" colspan="1">0.008</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LV end-systolic volume index, mL/m<sup>2</sup></td>
                          <td align="center" rowspan="1" colspan="1">0.402</td>
                          <td align="center" rowspan="1" colspan="1">0.003</td>
                          <td align="center" rowspan="1" colspan="1">0.289</td>
                          <td align="center" rowspan="1" colspan="1">0.003</td>
                          <td align="center" rowspan="1" colspan="1">0.351</td>
                          <td align="center" rowspan="1" colspan="1">0.005</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Stroke volume index, ml</td>
                          <td align="center" rowspan="1" colspan="1">-0.111</td>
                          <td align="center" rowspan="1" colspan="1">0.428</td>
                          <td align="center" rowspan="1" colspan="1">-0.038</td>
                          <td align="center" rowspan="1" colspan="1">0.700</td>
                          <td align="center" rowspan="1" colspan="1">0.082</td>
                          <td align="center" rowspan="1" colspan="1">0.525</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LVMI, mg/m<sup>2</sup></td>
                          <td align="center" rowspan="1" colspan="1">-0.493</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">-0.329</td>
                          <td align="center" rowspan="1" colspan="1">0.001</td>
                          <td align="center" rowspan="1" colspan="1">-0.328</td>
                          <td align="center" rowspan="1" colspan="1">0.009</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Maximum LVWT, mm</td>
                          <td align="center" rowspan="1" colspan="1">0.419</td>
                          <td align="center" rowspan="1" colspan="1">0.002</td>
                          <td align="center" rowspan="1" colspan="1">0.429</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">0.068</td>
                          <td align="center" rowspan="1" colspan="1">0.600</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Percentage of LGE, %</td>
                          <td align="center" rowspan="1" colspan="1">0.132</td>
                          <td align="center" rowspan="1" colspan="1">0.455</td>
                          <td align="center" rowspan="1" colspan="1">0.367</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">-</td>
                          <td align="center" rowspan="1" colspan="1">-</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LGE volume, ml</td>
                          <td align="center" rowspan="1" colspan="1">0.146</td>
                          <td align="center" rowspan="1" colspan="1">0.411</td>
                          <td align="center" rowspan="1" colspan="1">0.380</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">-</td>
                          <td align="center" rowspan="1" colspan="1">-</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Global native T<sub>1</sub>, ms</td>
                          <td align="center" rowspan="1" colspan="1">0.175</td>
                          <td align="center" rowspan="1" colspan="1">0.174</td>
                          <td align="center" rowspan="1" colspan="1">0.483</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">0.137</td>
                          <td align="center" rowspan="1" colspan="1">0.285</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>LGE, late gadolinium enhancement; LVMI, left ventricular mass index; LVWT, left ventricular wall thickness.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Two multiple linear regression models, each including 1 variable representing extent of hypertrophy (LV mass index, maximal LVWT) and global native T<sub>1</sub> (all adjusted by age and sex), revealed the independent role that extent of hypertrophy plays in the attenuation of GLS in HCM (standardized regression coefficients and P values for the 2 tested variables: 0.39, P&lt;0.001 each) and in HHD patients (standardized regression coefficients and P values for the 2 tested variables: 0.51, P&lt;0.001; 0.30, P = 0.032, respectively). Global native T<sub>1</sub> did not contribute significantly (P&gt;0.05) to these regression models. An exchange of global native T<sub>1</sub> with LGE volume provided similar results in HCM patients (standardized regression coefficients and P values for the 2 tested variables: 0.388, P&lt;0.001; 0.386, P&lt;0.001, respectively), and showed a significant contribution of LGE to the regression models (standardized regression coefficient and P values of LGE volume for the each model: 0.186, P = 0.030; 0.172, P = 0.049, respectively).</p>
              </sec>
              <sec id="sec013">
                <title>Discrimination between HHD and HCM</title>
                <p>In univariate analysis, GLS had diagnostic accuracies similar to hypertrophy and fibrosis markers (<xref rid="pone.0221061.t004" ref-type="table">Table 4</xref>, <xref ref-type="fig" rid="pone.0221061.g004">Fig 4</xref>). Areas under the ROC curves comparison between GLS and global native T<sub>1</sub> (P = 0.131), LGE volume (P = 0.100), or LV mass index (P = 0.967) showed no significant differences. In a multivariate binary logistic regression analysis including the prevalence of LVH and GLS, a trend for GLS to independently discriminate between HCM and HHD was observed (P = 0.066). With a sensitivity of 68% and a specificity of 64%, the model had a better test accuracy than each of its parts. In a multivariate logistic regression with forward selection of all markers represented in <xref rid="pone.0221061.t004" ref-type="table">Table 4</xref>, only global native T<sub>1</sub> (P = 0.015) and LGE prevalence (P = 0.018) remained significantly associated with disease prediction.</p>
                <fig id="pone.0221061.g004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0221061.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>Discrimination of HHD and HCM by CMR markers.</title>
                    <p>Receiver-operating characteristic curves in discrimination between HHD and HCM for single CMR markers and the multivariate regression model listed in <xref rid="pone.0221061.t004" ref-type="table">Table 4</xref> (GLS and LV hypertrophy (yes/no)).</p>
                  </caption>
                  <graphic xlink:href="pone.0221061.g004"/>
                </fig>
                <table-wrap id="pone.0221061.t004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0221061.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Results of ROC and binary logistic regression analyses of CMR parameters for discrimination of HHD vs. HCM subjects.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0221061.t004g" xlink:href="pone.0221061.t004"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="justify" rowspan="1" colspan="1">Biomarker</th>
                          <th align="center" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Specificity (95% CI)</th>
                          <th align="center" rowspan="1" colspan="1">Sensitivity (95% CI)</th>
                          <th align="center" rowspan="1" colspan="1">PPV (95% CI)</th>
                          <th align="center" rowspan="1" colspan="1">NPV (95% CI)</th>
                          <th align="center" rowspan="1" colspan="1">Diagnostic Accuracy (95% CI)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Univariate Analysis</td>
                          <td align="center" rowspan="1" colspan="1">AUC (95% CI)</td>
                          <td align="center" rowspan="1" colspan="1">Cut-off Values</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    GLS, %</td>
                          <td align="center" rowspan="1" colspan="1">0.639 (0.550–0.729)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
                          <td align="center" rowspan="1" colspan="1">-15.7</td>
                          <td align="center" rowspan="1" colspan="1">72 (58–83)</td>
                          <td align="center" rowspan="1" colspan="1">58 (48–67)</td>
                          <td align="center" rowspan="1" colspan="1">81 (72–87)</td>
                          <td align="center" rowspan="1" colspan="1">46 (39–53)</td>
                          <td align="center" rowspan="1" colspan="1">63 (55–70)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Global Native T<sub>1</sub>, ms</td>
                          <td align="center" rowspan="1" colspan="1">0.718 (0.638–0.799)<xref ref-type="table-fn" rid="t004fn003"><sup>†</sup></xref></td>
                          <td align="center" rowspan="1" colspan="1">1097</td>
                          <td align="center" rowspan="1" colspan="1">92 81–98)</td>
                          <td align="center" rowspan="1" colspan="1">50 (40–59)</td>
                          <td align="center" rowspan="1" colspan="1">93 (84–97)</td>
                          <td align="center" rowspan="1" colspan="1">47 (42–52)</td>
                          <td align="center" rowspan="1" colspan="1">64 (56–71)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    LGE (present)</td>
                          <td align="center" rowspan="1" colspan="1">0.656 (0.551–0.760)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
                          <td align="center" rowspan="1" colspan="1">…</td>
                          <td align="center" rowspan="1" colspan="1">74 (56–87)</td>
                          <td align="center" rowspan="1" colspan="1">58 (47–67)</td>
                          <td align="center" rowspan="1" colspan="1">86 (80–92)</td>
                          <td align="center" rowspan="1" colspan="1">37 (30–45)</td>
                          <td align="center" rowspan="1" colspan="1">61 (53–70)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    LGE volume, ml</td>
                          <td align="center" rowspan="1" colspan="1">0.680 (0.585–0.775)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
                          <td align="center" rowspan="1" colspan="1">0.15</td>
                          <td align="center" rowspan="1" colspan="1">79 (62–91)</td>
                          <td align="center" rowspan="1" colspan="1">56 (45–66)</td>
                          <td align="center" rowspan="1" colspan="1">89 (80–94)</td>
                          <td align="center" rowspan="1" colspan="1">39 (32–45)</td>
                          <td align="center" rowspan="1" colspan="1">62 (53–70)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    LV hypertrophy (present)</td>
                          <td align="center" rowspan="1" colspan="1">0.621 (0.531–0.710)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
                          <td align="center" rowspan="1" colspan="1">81 (♂), 61 (♀)[<xref rid="pone.0221061.ref029" ref-type="bibr">29</xref>]</td>
                          <td align="center" rowspan="1" colspan="1">79 (66–89)</td>
                          <td align="center" rowspan="1" colspan="1">45 (35–55)</td>
                          <td align="center" rowspan="1" colspan="1">81 (71–88)</td>
                          <td align="center" rowspan="1" colspan="1">42 (36–47)</td>
                          <td align="center" rowspan="1" colspan="1">56 (48–64)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    LV mass index, g/m<sup>2</sup></td>
                          <td align="center" rowspan="1" colspan="1">0.643 (0.556–0.731)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
                          <td align="center" rowspan="1" colspan="1">65.2</td>
                          <td align="center" rowspan="1" colspan="1">66 (52–78)</td>
                          <td align="center" rowspan="1" colspan="1">64 (55–74)</td>
                          <td align="center" rowspan="1" colspan="1">79 (72–85)</td>
                          <td align="center" rowspan="1" colspan="1">48 (40–56)</td>
                          <td align="center" rowspan="1" colspan="1">65 (57–72)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Multivariate analysis</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">Wald</td>
                          <td align="center" rowspan="1" colspan="1">Exp(B) (95% CI)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    GLS, %</td>
                          <td align="center" rowspan="1" colspan="1">3.380</td>
                          <td align="center" rowspan="1" colspan="1">1.102 (0.994–1.223)</td>
                          <td align="center" rowspan="2" colspan="1">64 (50–77)</td>
                          <td align="center" rowspan="2" colspan="1">68 (59–77)</td>
                          <td align="center" rowspan="2" colspan="1">79 (72–85)</td>
                          <td align="center" rowspan="2" colspan="1">50 (42–58)</td>
                          <td align="center" rowspan="2" colspan="1">67 (59–74)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    LV hypertrophy (y/n)</td>
                          <td align="center" rowspan="1" colspan="1">4.227</td>
                          <td align="center" rowspan="1" colspan="1">0.424 (0.187–0.961)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t004fn001">
                      <p>For the multivariate model: χ<sup>2</sup>: 12.7, P = 0.002; -2Log LH:190.5, Cox &amp; Snell R<sup>2</sup>:0.077, Nagelkerke R<sup>2</sup>: 0.107. Youden’s indexes for GLS, global native T1, LGE volume, LV mass index and the multivariable analysis were 0.296, 0.418, 0.351, 0.305 and 0.324, respectively. Gender specific cut-off values for LV mass index were used to define LV hypertrophy [<xref rid="pone.0221061.ref029" ref-type="bibr">29</xref>]. AUC, area under the curve; CI, confidence interval; GLS, global longitudinal strain; HCM, hypertrophic cardiomyopathy; LGE, late gadolinium enhancement; LH likelihood; LV, left ventricle; LVEF, LV ejection fraction; LVWT, LV wall thickness; NPV, negative predictive value; PPV, positive predictive value; ROC, receiver operating characteristics</p>
                    </fn>
                    <fn id="t004fn002">
                      <p>*P&lt;0.05</p>
                    </fn>
                    <fn id="t004fn003">
                      <p><sup>†</sup>P&lt;0.001.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec014">
                <title>CMR measurement reproducibility</title>
                <p>The intra- (ICC 0.96, 95% CI 0.90–0.98) and interobserver agreement (ICC 0.94, 95% CI 0.84–0.98) for CMR-FT GLS measurements was excellent. Bland-Altman analyses showed narrow limits of agreement for GLS on intra- and interobserver level (<xref ref-type="fig" rid="pone.0221061.g005">Fig 5</xref>). The inter-observer agreement for LGE quantification (ICC 0.88, 95% CI 0.58–0.96) and global native T<sub>1</sub> (ICC 0.95, 95% CI 0.90–0.97) was excellent as well.</p>
                <fig id="pone.0221061.g005" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0221061.g005</object-id>
                  <label>Fig 5</label>
                  <caption>
                    <title>CMR-FT GLS reproducibility.</title>
                    <p>Linear Regression and Bland-Altman plots illustrating intra- (A, C) and interobserver variability (B, D) of global longitudinal strain (GLS) measurements in a subset of randomly selected patients.</p>
                  </caption>
                  <graphic xlink:href="pone.0221061.g005"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec015">
              <title>Discussion</title>
              <p>Our work investigated the role of CMR-FT in the assessment of patients with increased LVWT and showed that GLS differentiates between two of the most prevalent disease with this phenotype, HHD and HCM. This finding is consistent with publications employing STE strain assessment [<xref rid="pone.0221061.ref010" ref-type="bibr">10</xref>–<xref rid="pone.0221061.ref012" ref-type="bibr">12</xref>]. Considering CMR’s advantages over echocardiography (i.e. no interference from adjacent bone or air, decreased operator dependency) and as CMR-FT could be CMR’s answer to STE for acquisition of global strain information [<xref rid="pone.0221061.ref039" ref-type="bibr">39</xref>], our study confirms its relevance for the increased LVWT phenotype.</p>
              <p>In subgroup analysis, the distinction between HHD and HCM was limited to patients with increased LVWT in the absence of LVH. Difficulties to differentiate diseases by CMR-FT GLS in the presence of LVH have been reported by Rodrigues et al., where HHD patients had a 17% higher LV mass index when compared to HCM patients [<xref rid="pone.0221061.ref040" ref-type="bibr">40</xref>]. In hypertensive patients GLS is more abnormal in the presence of LVH and correlates with LV mass index [<xref rid="pone.0221061.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0221061.ref041" ref-type="bibr">41</xref>] indicating that contractility decline worsens with disease progression. In HCM, GLS decline occurs already prior to phenotype development [<xref rid="pone.0221061.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0221061.ref042" ref-type="bibr">42</xref>]. Our finding that GLS is able to differentiate between cohorts with similar LV mass index in the absence of LVH may therefore reflect on a relative delay in GLS attenuation when comparing HHD to HCM disease progression. Related, GLS of healthy control subjects was significantly different from HCM<sub>LVH-</sub>, and HHD<sub>LVH+</sub> patients, but similar to HHD<sub>LVH-</sub> patients.</p>
              <sec id="sec016">
                <title>Relationship between longitudinal strain and fibrosis</title>
                <p>Our findings demonstrate that hypertrophy has a larger impact on CMR-FT GLS than diffuse and replacement fibrosis, as measured by native T<sub>1</sub> and LGE, respectively. These findings were consistent with published STE and CMR-FT data [<xref rid="pone.0221061.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0221061.ref023" ref-type="bibr">23</xref>]. Interestingly, the visualized overlap between large areas of LGE and myocardial regions with significantly attenuated strain suggests that replacement fibrosis impacts on regional deformation in HCM patients [<xref rid="pone.0221061.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0221061.ref043" ref-type="bibr">43</xref>]. Related LGE was present in HHD and HCM patients with impaired longitudinal contractility. As previously shown by others [<xref rid="pone.0221061.ref044" ref-type="bibr">44</xref>–<xref rid="pone.0221061.ref046" ref-type="bibr">46</xref>], GLS correlated also with LGE extent in our HCM cohort. The investigation of LGE positive cases in isolation however showed no relationship. An artificial association between GLS and LGE extent created by the inclusion of LGE- cases is therefore possible. Yet, the small number of HCM cases with large LGE percentage (%LGE &gt;10%, n = 6) might have contributed to this observation. Diffuse fibrosis correlated in HCM patients with GLS suggesting its contribution to longitudinal contractility decline [<xref rid="pone.0221061.ref023" ref-type="bibr">23</xref>]. In HHD patients fibrosis markers and longitudinal strain were not linked, which may reflect the weaker association between hypertrophy and fibrosis in hypertensive patients [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>].</p>
              </sec>
              <sec id="sec017">
                <title>Discrimination between HHD and HCM</title>
                <p>We provide evidence for CMR-FT GLS’s capacity to differentiate between HHD and HCM. Conclusions regarding the magnitude of its diagnostic capacity require consideration of other cardiac imaging markers. For instance, both diseases have focal LGE [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0221061.ref047" ref-type="bibr">47</xref>–<xref rid="pone.0221061.ref050" ref-type="bibr">50</xref>], increased native T<sub>1</sub> [<xref rid="pone.0221061.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0221061.ref047" ref-type="bibr">47</xref>]<sub>,</sub> diastolic dysfunction [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>], as well as LVH [<xref rid="pone.0221061.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0221061.ref049" ref-type="bibr">49</xref>] in common. Taking potential co-occurrences of hypertension and HCM into account, the diagnosis based on cardiac imaging alone remains often uncertain [<xref rid="pone.0221061.ref032" ref-type="bibr">32</xref>].</p>
                <p>Focal fibrosis has been detected in both disease [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0221061.ref047" ref-type="bibr">47</xref>–<xref rid="pone.0221061.ref050" ref-type="bibr">50</xref>]. Most studies report differences for the comparison of HCM and HHD patients [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0221061.ref048" ref-type="bibr">48</xref>,<xref rid="pone.0221061.ref049" ref-type="bibr">49</xref>]. Likewise our data showed that LGE is more extensive and prevalent in HCM patients. Linked to the quantity of smaller LGE quantities (i.e. &lt;1%LGE, n = 24 and n = 6 in HCM and HHD patients, respectively), LGE volume and prevalence provide similar test accuracies in our cohort. However LGE quantification may provide the stronger diagnostic marker [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0221061.ref048" ref-type="bibr">48</xref>,<xref rid="pone.0221061.ref049" ref-type="bibr">49</xref>]. For instance, Rudolph et al. show that %LGE but not LGE prevalence significantly differentiated between HHD and HCM patients [<xref rid="pone.0221061.ref048" ref-type="bibr">48</xref>]. Also the larger range of %LGE values in HCM [<xref rid="pone.0221061.ref035" ref-type="bibr">35</xref>] could facilitate its discriminatory ability.</p>
                <p>Comparable to GLS [<xref rid="pone.0221061.ref010" ref-type="bibr">10</xref>–<xref rid="pone.0221061.ref012" ref-type="bibr">12</xref>] and LGE [<xref rid="pone.0221061.ref048" ref-type="bibr">48</xref>], the clinical application of myocardial native T<sub>1</sub> mapping is limited by the overlapping data distribution between patients with different cardiac pathologies [<xref rid="pone.0221061.ref047" ref-type="bibr">47</xref>,<xref rid="pone.0221061.ref051" ref-type="bibr">51</xref>]. In HCM patients global native T<sub>1</sub> is associated with LV mass index and LVWT [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0221061.ref052" ref-type="bibr">52</xref>]. In our cohort the average LV mass index difference between HHD and HCM was only 13 g/m<sup>2</sup>. Thus, relatively small phenotypic differences influenced probably our results. Furthermore, myocardial native T<sub>1</sub> values and LVWT are correlated on segmental level [<xref rid="pone.0221061.ref052" ref-type="bibr">52</xref>]. By inclusion of larger quantities of non-hypertrophied segments, our whole heart coverage resulted in relatively low native T<sub>1</sub> values despite regional hypertrophy. The diagnostic capacity of myocardial native T<sub>1</sub> in our study differed from data reported by Hinojar et al. [<xref rid="pone.0221061.ref022" ref-type="bibr">22</xref>]. Next to phenotype severity and heterogeneity, differences in T1 mapping sequences probably contributed to this observation. As shown by Child et al. [<xref rid="pone.0221061.ref053" ref-type="bibr">53</xref>], T<sub>1</sub> mapping sequences differ in their bioequivalence for discrimination between different cohorts. Therefore the use of different T<sub>1</sub> mapping sequences, such as the modified Look-Locker imaging (MOLLI) sequence [<xref rid="pone.0221061.ref053" ref-type="bibr">53</xref>] or the slice-interleaved T<sub>1</sub> mapping (STONE) sequence [<xref rid="pone.0221061.ref036" ref-type="bibr">36</xref>], could result in altered test accuracies.</p>
                <p>Several studies reported differentiation between HHD and HCM by STE longitudinal strain [<xref rid="pone.0221061.ref010" ref-type="bibr">10</xref>–<xref rid="pone.0221061.ref013" ref-type="bibr">13</xref>]. Also longitudinal strain, defined as systolic shortening of the LV walls relative to its diastolic length on CMR cine images, was successfully applied by Puntmann et al. [<xref rid="pone.0221061.ref049" ref-type="bibr">49</xref>]. Data on CMR-FT strain is limited to the publication by Rodrigues et al. [<xref rid="pone.0221061.ref040" ref-type="bibr">40</xref>]. The authors reported that longitudinal strain is unable to differentiate between HHD and HCM patients with maximal LVWT ≥15 mm. These STE and CMR studies as well as our results have an overlapping data distribution in common. CMR-FT GLS contributes therefore similarly to the diagnostic process as myocardial tissue characterization and LV hypertrophy assessment, a finding that highlights the diagnostic challenge presented by patients with increased LVWT. Novel CMR imaging approaches, such as radiomic analyses of quantitative CMR images [<xref rid="pone.0221061.ref027" ref-type="bibr">27</xref>] or diffusion tensor CMR [<xref rid="pone.0221061.ref054" ref-type="bibr">54</xref>], have the potential to improve the diagnostic accuracy of cardiac imaging. In opposite to CMR-FT and established CMR tissue characterization techniques, these novel approaches are however not widely available.</p>
              </sec>
              <sec id="sec018">
                <title>Limitations</title>
                <p>Our study has several limitations. To adjust for the diagnostic criteria of HCM, LVWT ≥15 mm rather than LV hypertrophy [<xref rid="pone.0221061.ref003" ref-type="bibr">3</xref>], we defined HHD based on presence of increased LVWT [<xref rid="pone.0221061.ref030" ref-type="bibr">30</xref>] instead of LVH [<xref rid="pone.0221061.ref001" ref-type="bibr">1</xref>]. Secondly, our analyses were based on GLS assessment only, whilst other parameters of myocardial mechanics might provide additional clinical relevant information. Although large size studies are required to address an incremental value of GLS in addition to established morphological CMR markers, our study suggests a lack of such. Furthermore, functional parameters, such as LV outflow tract gradients and diastolic dysfunction [<xref rid="pone.0221061.ref032" ref-type="bibr">32</xref>], were not considered. Finally, our findings are based on a small single center cohort using a 1.5T CMR scanner and single CMR-FT software, whilst larger multicenter, multivendor studies are required to validate our results for widespread clinical application.</p>
              </sec>
              <sec id="sec019">
                <title>Conclusions</title>
                <p>Our study demonstrated that CMR-FT GLS differentiates HHD from HCM. This distinction is mostly observed in patients with increased LVWT and absence of LVH. GLS’s diagnostic accuracy is similar to CMR markers of myocardial fibrosis and LVH. However GLS’s discriminatory ability limits its clinical application and emphasizes the difficulty to differentiate the two diseases based on cardiac imaging alone.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material" id="sec020">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pone.0221061.s001">
                <label>S1 Table</label>
                <caption>
                  <title>Demographic data and cohort characteristics in subjects with late gadolinium enhancement.</title>
                  <p>LV, left ventricular; LVWT, LV wall thickness. * P&lt;0.001 compared with HHD; † P&lt;0.01 compared with HHD; ‡ P&lt;0.02 compared with HHD; § P&lt;0.001 compared with healthy controls; ǁ P&lt;0.01 compared with healthy controls; # P&lt;0.02 compared with healthy controls. P values were Bonferroni corrected (0.05/3) to account for multiple cohort comparisons.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0221061.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0221061.s002">
                <label>S2 Table</label>
                <caption>
                  <title>Logistic regression models for discrimination of HHD and HCM.</title>
                  <p>GLS, global longitudinal strain; LGE, late gadolinium enhancement; LV, left ventricle; LVWT, LV wall thickness.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0221061.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0221061.s003">
                <label>S3 Table</label>
                <caption>
                  <title>Cardiovascular magnetic resonance parameters in the HCM group according to LV hypertrophy type.</title>
                  <p>LGE, late gadolinium enhancement; LV, left ventricular; RV, right ventricular. * P&lt;0.001 compared with asymmetric HCM; † P&lt;0.02 compared with asymmetric HCM; ‡ P&lt;0.001 compared with concentric HCM; § P&lt;0.02 compared with concentric HCM. P values were Bonferroni corrected (0.05/3) to account for multiple cohort comparisons.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0221061.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0221061.s004">
                <label>S4 Table</label>
                <caption>
                  <title>CMR characteristics of the equal LVWT subgroup.</title>
                  <p>HCM, hypertrophic cardiomyopathy; HHD, hypertensive heart disease; LVWT, left ventricular wall thickness. Clinical characteristics of the equal LVWT subgroup have been reported elsewhere [<xref rid="pone.0221061.ref001" ref-type="bibr">1</xref>].</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0221061.s004.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0221061.s005">
                <label>S1 Data</label>
                <caption>
                  <title>Complete set of presented data.</title>
                  <p>(XLS)</p>
                </caption>
                <media xlink:href="pone.0221061.s005.xls">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>The authors thank Beth Goddu, RTR(MR), Patrick Pierce, BSRT(MR) and Sophie Berg, RNBSN for their help with CMR scanning and patient management.</p>
            </ack>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>CMR</term>
                  <def>
                    <p>Cardiovascular magnetic resonance imaging</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CMR-FT</term>
                  <def>
                    <p>Cardiovascular magnetic resonance myocardial feature tracking</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GLS</term>
                  <def>
                    <p>Global longitudinal strain</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HHD</term>
                  <def>
                    <p>Hypertensive heart disease</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HCM</term>
                  <def>
                    <p>Hypertrophic cardiomyopathy</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LGE</term>
                  <def>
                    <p>Late gadolinium enhancement</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LV</term>
                  <def>
                    <p>Left ventricular</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LVEF</term>
                  <def>
                    <p>Left ventricular ejection fraction</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LVH</term>
                  <def>
                    <p>Left ventricular hypertrophy</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LVWT</term>
                  <def>
                    <p>Left ventricular wall thickness</p>
                  </def>
                </def-item>
                <def-item>
                  <term>STE</term>
                  <def>
                    <p>Speckle-tracking echocardiography</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="pone.0221061.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Lip</surname><given-names>GYH</given-names></name>, <name><surname>Felmeden</surname><given-names>DC</given-names></name>, <name><surname>Li-Saw-Hee</surname><given-names>FL</given-names></name>, <name><surname>Beevers</surname><given-names>DG</given-names></name>. <article-title>Hypertensive heart disease: A complex syndrome or a hypertensive “cardiomyopathy”?</article-title><source>Eur Heart J</source>. <year>2000</year>;<volume>21</volume>: <fpage>1653</fpage>–<lpage>1665</lpage>. <pub-id pub-id-type="doi">10.1053/euhj.2000.2339</pub-id>
<?supplied-pmid 11032692?><pub-id pub-id-type="pmid">11032692</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Gersh</surname><given-names>BJ</given-names></name>, <name><surname>Maron</surname><given-names>BJ</given-names></name>, <name><surname>Bonow</surname><given-names>RO</given-names></name>, <name><surname>Dearani</surname><given-names>JA</given-names></name>, <name><surname>Fifer</surname><given-names>MA</given-names></name>, <name><surname>Link</surname><given-names>MS</given-names></name>, <etal>et al</etal><article-title>2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</article-title>. <source>Circulation</source>. <year>2011</year>;<volume>124</volume>: <fpage>2761</fpage>–<lpage>2796</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0b013e318223e230</pub-id>
<?supplied-pmid 22068435?><pub-id pub-id-type="pmid">22068435</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Elliott</surname><given-names>PM</given-names></name>, <name><surname>Uk</surname><given-names>C</given-names></name>, <name><surname>Anastasakis</surname><given-names>A</given-names></name>, <name><surname>Germany</surname><given-names>MAB</given-names></name>, <name><surname>Germany</surname><given-names>MB</given-names></name>, <name><surname>Cecchi</surname><given-names>F</given-names></name>, <etal>et al</etal><article-title>2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy</article-title>. <source>Eur Heart J</source>. <year>2014</year>;<volume>35</volume>: <fpage>2733</fpage>–<lpage>2779</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehu284</pub-id>
<?supplied-pmid 25173338?><pub-id pub-id-type="pmid">25173338</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Rodrigues</surname><given-names>JCL</given-names></name>, <name><surname>Amadu</surname><given-names>AM</given-names></name>, <name><surname>Dastidar</surname><given-names>AG</given-names></name>, <name><surname>Szantho</surname><given-names>G V</given-names></name>, <name><surname>Lyen</surname><given-names>SM</given-names></name>, <name><surname>Godsave</surname><given-names>C</given-names></name>, <etal>et al</etal><article-title>Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes</article-title>. <source>Heart</source>. <year>2016</year>;<volume>102</volume>: <fpage>1671</fpage>–<lpage>1679</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2016-309576</pub-id>
<?supplied-pmid 27260191?><pub-id pub-id-type="pmid">27260191</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Kuruvilla</surname><given-names>S</given-names></name>, <name><surname>Janardhanan</surname><given-names>R</given-names></name>, <name><surname>Antkowiak</surname><given-names>P</given-names></name>, <name><surname>Keeley</surname><given-names>EC</given-names></name>, <name><surname>Adenaw</surname><given-names>N</given-names></name>, <name><surname>Brooks</surname><given-names>J</given-names></name>, <etal>et al</etal><article-title>Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone</article-title>. <source>JACC Cardiovasc Imaging</source>. <year>2015</year>;<volume>8</volume>: <fpage>172</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmg.2014.09.020</pub-id>
<?supplied-pmid 25577446?><pub-id pub-id-type="pmid">25577446</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Saito</surname><given-names>M</given-names></name>, <name><surname>Khan</surname><given-names>F</given-names></name>, <name><surname>Stoklosa</surname><given-names>T</given-names></name>, <name><surname>Iannaccone</surname><given-names>A</given-names></name>, <name><surname>Negishi</surname><given-names>K</given-names></name>, <name><surname>Marwick</surname><given-names>TH</given-names></name>. <article-title>Prognostic implications of LV strain risk score in asymptomatic patients with hypertensive heart disease</article-title>. <source>JACC Cardiovasc Imaging</source>. <year>2016</year>;<volume>9</volume>: <fpage>911</fpage>–<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmg.2015.09.027</pub-id>
<?supplied-pmid 27344417?><pub-id pub-id-type="pmid">27344417</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Urbano-Moral</surname><given-names>JA</given-names></name>, <name><surname>Rowin</surname><given-names>EJ</given-names></name>, <name><surname>Maron</surname><given-names>MS</given-names></name>, <name><surname>Crean</surname><given-names>A</given-names></name>, <name><surname>Pandian</surname><given-names>NG</given-names></name>. <article-title>Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy</article-title>. <source>Circ Cardiovasc Imaging</source>. <year>2014</year>;<volume>7</volume>: <fpage>11</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCIMAGING.113.000842</pub-id>
<?supplied-pmid 24275954?><pub-id pub-id-type="pmid">24275954</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Imbalzano</surname><given-names>E</given-names></name>, <name><surname>Zito</surname><given-names>C</given-names></name>, <name><surname>Carerj</surname><given-names>S</given-names></name>, <name><surname>Oreto</surname><given-names>G</given-names></name>, <name><surname>Mandraffino</surname><given-names>G</given-names></name>, <name><surname>Cusmà-Piccione</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Left ventricular function in hypertension: New insight by speckle tracking echocardiography</article-title>. <source>Echocardiography</source>. <year>2011</year>;<volume>28</volume>: <fpage>649</fpage>–<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8175.2011.01410.x</pub-id>
<?supplied-pmid 21676016?><pub-id pub-id-type="pmid">21676016</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Carasso</surname><given-names>S</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name>, <name><surname>Woo</surname><given-names>A</given-names></name>, <name><surname>Vannan</surname><given-names>MA</given-names></name>, <name><surname>Jamorski</surname><given-names>M</given-names></name>, <name><surname>Wigle</surname><given-names>ED</given-names></name>, <etal>et al</etal><article-title>Systolic myocardial mechanics in hypertrophic cardiomyopathy: Novel concepts and implications for clinical status</article-title>. <source>J Am Soc Echocardiogr</source>. <year>2008</year>;<volume>21</volume>: <fpage>675</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1016/j.echo.2007.10.021</pub-id>
<?supplied-pmid 18187306?><pub-id pub-id-type="pmid">18187306</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Badran</surname><given-names>HM</given-names></name>, <name><surname>Faheem</surname><given-names>N</given-names></name>, <name><surname>Ibrahim</surname><given-names>WA</given-names></name>, <name><surname>Elnoamany</surname><given-names>MF</given-names></name>, <name><surname>Elsedi</surname><given-names>M</given-names></name>, <name><surname>Yacoub</surname><given-names>M</given-names></name>. <article-title>Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: Comparison with essential hypertension</article-title>. <source>J Am Soc Echocardiogr</source>. <year>2013</year>;<volume>26</volume>: <fpage>1397</fpage>–<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1016/j.echo.2013.08.026</pub-id>
<?supplied-pmid 24094559?><pub-id pub-id-type="pmid">24094559</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>JP</given-names></name>, <name><surname>Xu</surname><given-names>TY</given-names></name>, <name><surname>Ni</surname><given-names>X Da</given-names></name>, <name><surname>Yang</surname><given-names>XS</given-names></name>, <name><surname>Hu</surname><given-names>JL</given-names></name>, <name><surname>Wang</surname><given-names>SC</given-names></name>, <etal>et al</etal><article-title>Echocardiographic strain in hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy</article-title>. <source>Echocardiography</source>. <year>2019</year>;<volume>36</volume>: <fpage>257</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1111/echo.14222</pub-id>
<?supplied-pmid 30561121?><pub-id pub-id-type="pmid">30561121</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Minoshima</surname><given-names>M</given-names></name>, <name><surname>Noda</surname><given-names>A</given-names></name>, <name><surname>Nishizawa</surname><given-names>T</given-names></name>, <name><surname>Hara</surname><given-names>Y</given-names></name>, <name><surname>Sugiura</surname><given-names>M</given-names></name>, <name><surname>Iino</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>Endomyocardial radial strain imaging and left ventricular relaxation abnormalities in patients with hypertrophic cardiomyopathy or hypertensive left ventricular hypertrophy</article-title>. <source>Circ J</source>. <year>2009</year>;<volume>73</volume>: <fpage>2294</fpage>–<lpage>2299</lpage>. <pub-id pub-id-type="doi">10.1253/circj.cj-08-0879</pub-id>
<?supplied-pmid 19838000?><pub-id pub-id-type="pmid">19838000</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Kato</surname><given-names>TS</given-names></name>, <name><surname>Noda</surname><given-names>A</given-names></name>, <name><surname>Izawa</surname><given-names>H</given-names></name>, <name><surname>Yamada</surname><given-names>A</given-names></name>, <name><surname>Obata</surname><given-names>K</given-names></name>, <name><surname>Nagata</surname><given-names>K</given-names></name>, <etal>et al</etal><article-title>Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography</article-title>. <source>Circulation</source>. <year>2004</year>;<volume>110</volume>: <fpage>3808</fpage>–<lpage>3814</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000150334.69355.00</pub-id>
<?supplied-pmid 15583080?><pub-id pub-id-type="pmid">15583080</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Haland</surname><given-names>TF</given-names></name>, <name><surname>Hasselberg</surname><given-names>NE</given-names></name>, <name><surname>Almaas</surname><given-names>VM</given-names></name>, <name><surname>Dejgaard</surname><given-names>LA</given-names></name>, <name><surname>Saberniak</surname><given-names>J</given-names></name>, <name><surname>Leren</surname><given-names>IS</given-names></name>, <etal>et al</etal><article-title>The systolic paradox in hypertrophic cardiomyopathy</article-title>. <source>Open Heart</source>. <year>2017</year>;<volume>4</volume><pub-id pub-id-type="doi">10.1136/openhrt-2016-000571</pub-id><?supplied-pmid 28674623?><pub-id pub-id-type="pmid">28674623</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Ishizu</surname><given-names>T</given-names></name>, <name><surname>Seo</surname><given-names>Y</given-names></name>, <name><surname>Kameda</surname><given-names>Y</given-names></name>, <name><surname>Kawamura</surname><given-names>R</given-names></name>, <name><surname>Kimura</surname><given-names>T</given-names></name>, <name><surname>Shimojo</surname><given-names>N</given-names></name>, <etal>et al</etal><article-title>Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease</article-title>. <source>Hypertension</source>. <year>2014</year>;<volume>63</volume>: <fpage>500</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.02149</pub-id>
<?supplied-pmid 24396022?><pub-id pub-id-type="pmid">24396022</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Kobayashi</surname><given-names>T</given-names></name>, <name><surname>Popovic</surname><given-names>Z</given-names></name>, <name><surname>Bhonsale</surname><given-names>A</given-names></name>, <name><surname>Smedira</surname><given-names>N</given-names></name>, <name><surname>Tan</surname><given-names>C</given-names></name>, <name><surname>Rodriguez</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy</article-title>. <source>Am Hear J</source>. <year>2013</year>;<volume>166</volume>: <fpage>503</fpage>–<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1016/j.ahj.2013.06.011</pub-id>
<?supplied-pmid 24016500?><pub-id pub-id-type="pmid">24016500</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Davies</surname><given-names>MJ</given-names></name>, <name><surname>McKenna</surname><given-names>WJ</given-names></name>. <article-title>Hypertrophic cardiomyopathy—pathology and pathogenesis</article-title>. <source>Histopathology</source>. <year>1995</year>;<volume>26</volume>: <fpage>493</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2559.1995.tb00267.x</pub-id>
<?supplied-pmid 7665141?><pub-id pub-id-type="pmid">7665141</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Hughes</surname><given-names>SE</given-names></name>. <article-title>The pathology of hypertrophic cardiomyopathy</article-title>. <source>Histopathology</source>. <year>2004</year>;<volume>44</volume>: <fpage>412</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2559.2004.01835.x</pub-id>
<?supplied-pmid 15139989?><pub-id pub-id-type="pmid">15139989</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Rossi</surname><given-names>MA</given-names></name>. <article-title>Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans</article-title>. <source>J Hypertens</source>. <year>1998</year>;<volume>16</volume>: <fpage>1031</fpage>–<lpage>1041</lpage>. <pub-id pub-id-type="doi">10.1097/00004872-199816070-00018</pub-id>
<?supplied-pmid 9794745?><pub-id pub-id-type="pmid">9794745</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Moravsky</surname><given-names>G</given-names></name>, <name><surname>Ofek</surname><given-names>E</given-names></name>, <name><surname>Rakowski</surname><given-names>H</given-names></name>, <name><surname>Butany</surname><given-names>J</given-names></name>, <name><surname>Williams</surname><given-names>L</given-names></name>, <name><surname>Ralph-Edwards</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopatholgical findings by CMR</article-title>. <source>JACC Cardiovasc Imaging</source>. <year>2013</year>;<volume>6</volume>: <fpage>587</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmg.2012.09.018</pub-id>
<?supplied-pmid 23582356?><pub-id pub-id-type="pmid">23582356</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Flett</surname><given-names>AS</given-names></name>, <name><surname>Hayward</surname><given-names>MP</given-names></name>, <name><surname>Ashworth</surname><given-names>MT</given-names></name>, <name><surname>Hansen</surname><given-names>MS</given-names></name>, <name><surname>Taylor</surname><given-names>AM</given-names></name>, <name><surname>Elliott</surname><given-names>PM</given-names></name>, <etal>et al</etal><article-title>Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans</article-title>. <source>Circulation</source>. <year>2010</year>;<volume>122</volume>: <fpage>138</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.930636</pub-id>
<?supplied-pmid 20585010?><pub-id pub-id-type="pmid">20585010</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Hinojar</surname><given-names>R</given-names></name>, <name><surname>Varma</surname><given-names>N</given-names></name>, <name><surname>Child</surname><given-names>N</given-names></name>, <name><surname>Goodman</surname><given-names>B</given-names></name>, <name><surname>Jabbour</surname><given-names>A</given-names></name>, <name><surname>Yu</surname><given-names>CY</given-names></name>, <etal>et al</etal><article-title>T<sub>1</sub> mapping in discrimination of hypertrophic phenotypes: Hypertensive heart disease and hypertrophic cardiomyopathy: Findings from the international T<sub>1</sub> multicenter cardiovascular magnetic resonance study</article-title>. <source>Circ Cardiovasc Imaging</source>. <year>2015</year>;<volume>8</volume>: <fpage>e003285</fpage><pub-id pub-id-type="doi">10.1161/CIRCIMAGING.115.003285</pub-id><?supplied-pmid 26659373?><pub-id pub-id-type="pmid">26659373</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Swoboda</surname><given-names>PP</given-names></name>, <name><surname>McDiarmid</surname><given-names>AK</given-names></name>, <name><surname>Erhayiem</surname><given-names>B</given-names></name>, <name><surname>Law</surname><given-names>GR</given-names></name>, <name><surname>Garg</surname><given-names>P</given-names></name>, <name><surname>Broadbent</surname><given-names>DA</given-names></name>, <etal>et al</etal><article-title>Effect of cellular and extracellular pathology assessed by T<sub>1</sub> mapping on regional contractile function in hypertrophic cardiomyopathy</article-title>. <source>J Cardiovasc Magn Reson</source>. <year>2017</year>;<volume>19</volume>: <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1186/s12968-016-0318-2</pub-id><pub-id pub-id-type="pmid">28081721</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Schuster</surname><given-names>A</given-names></name>, <name><surname>Hor</surname><given-names>K</given-names></name>, <name><surname>Kowallick</surname><given-names>J</given-names></name>, <name><surname>Beerbaum</surname><given-names>P</given-names></name>, <name><surname>Kutty</surname><given-names>S</given-names></name>. <article-title>Cardiovascular magnetic resonance myocardial feature tracking: Concepts and cinical applications</article-title>. <source>Circ Cardiovasc Imaging</source>. <year>2016</year>;<volume>9</volume>: <fpage>e004077</fpage><pub-id pub-id-type="doi">10.1161/CIRCIMAGING.115.004077</pub-id><?supplied-pmid 27009468?><pub-id pub-id-type="pmid">27009468</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Schmidt</surname><given-names>B</given-names></name>, <name><surname>Dick</surname><given-names>A</given-names></name>, <name><surname>Treutlein</surname><given-names>M</given-names></name>, <name><surname>Schiller</surname><given-names>P</given-names></name>, <name><surname>Bunck</surname><given-names>AC</given-names></name>, <name><surname>Maintz</surname><given-names>D</given-names></name>, <etal>et al</etal><article-title>Intra- and inter-observer reproducibility of global and regional magnetic resonance feature tracking derived strain parameters of the left and right ventricle</article-title>. <source>Eur J Radiol</source>. <year>2017</year>;<volume>89</volume>: <fpage>97</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejrad.2017.01.025</pub-id>
<?supplied-pmid 28267556?><pub-id pub-id-type="pmid">28267556</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Padiyath</surname><given-names>A</given-names></name>, <name><surname>Gribben</surname><given-names>P</given-names></name>, <name><surname>Abraham</surname><given-names>JR</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Rangamani</surname><given-names>S</given-names></name>, <name><surname>Schuster</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Echocardiography and cardiac magnetic resonance-based feature tracking in the assessment of myocardial mechanics in tetralogy of Fallot: An intermodality comparison</article-title>. <source>Echocardiography</source>. <year>2013</year>;<volume>30</volume>: <fpage>203</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1111/echo.12016</pub-id>
<?supplied-pmid 23167248?><pub-id pub-id-type="pmid">23167248</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Neisius</surname><given-names>U</given-names></name>, <name><surname>El-Rewaidy</surname><given-names>H</given-names></name>, <name><surname>Nakamori</surname><given-names>S</given-names></name>, <name><surname>Rodriguez</surname><given-names>J</given-names></name>, <name><surname>Manning</surname><given-names>W</given-names></name>, <name><surname>Nezafat</surname><given-names>R</given-names></name>. <article-title>Radiomic analysis of myocardial native T<sub>1</sub> imaging discriminates between hypertensive heart disease and hypertrophic cardiomyopathy</article-title>. <source>JACC Cardiovasc Imaging</source>. <year>2019</year>; [Epub ahead of print]. <pub-id pub-id-type="doi">10.1016/j.jcmg.2018.11.024</pub-id><?supplied-pmid 30660549?><pub-id pub-id-type="pmid">30660549</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Chobanian</surname><given-names>A V.</given-names></name>, <name><surname>Bakris</surname><given-names>GL</given-names></name>, <name><surname>Black</surname><given-names>HR</given-names></name>, <name><surname>Cushman</surname><given-names>WC</given-names></name>, <name><surname>Green</surname><given-names>LA</given-names></name>, <name><surname>Izzo</surname><given-names>JL</given-names></name>, <etal>et al</etal><article-title>Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</article-title>. <source>Hypertension</source>. <year>2003</year>;<volume>42</volume>: <fpage>1206</fpage>–<lpage>1252</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.0000107251.49515.c2</pub-id>
<?supplied-pmid 14656957?><pub-id pub-id-type="pmid">14656957</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Olivotto</surname><given-names>I</given-names></name>, <name><surname>Maron</surname><given-names>MS</given-names></name>, <name><surname>Autore</surname><given-names>C</given-names></name>, <name><surname>Lesser</surname><given-names>JR</given-names></name>, <name><surname>Rega</surname><given-names>L</given-names></name>, <name><surname>Casolo</surname><given-names>G</given-names></name>, <etal>et al</etal><article-title>Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy</article-title>. <source>J Am Coll Cardiol</source>. <year>2008</year>;<volume>52</volume>: <fpage>559</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2008.04.047</pub-id>
<?supplied-pmid 18687251?><pub-id pub-id-type="pmid">18687251</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Salton</surname><given-names>CJ</given-names></name>, <name><surname>Chuang</surname><given-names>ML</given-names></name>, <name><surname>O’Donnell</surname><given-names>CJ</given-names></name>, <name><surname>Kupka</surname><given-names>MJ</given-names></name>, <name><surname>Larson</surname><given-names>MG</given-names></name>, <name><surname>Kissinger</surname><given-names>K V</given-names></name>, <etal>et al</etal><article-title>Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort</article-title>. <source>J Am Coll Cardiol</source>. <year>2002</year>;<volume>39</volume>: <fpage>1055</fpage>–<lpage>1060</lpage>. S0735109702017126 [pii] <pub-id pub-id-type="doi">10.1016/s0735-1097(02)01712-6</pub-id>
<?supplied-pmid 11897450?><pub-id pub-id-type="pmid">11897450</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Kawel-Boehm</surname><given-names>N</given-names></name>, <name><surname>Maceira</surname><given-names>A</given-names></name>, <name><surname>Valsangiacomo-Buechel</surname><given-names>ER</given-names></name>, <name><surname>Vogel-Claussen</surname><given-names>J</given-names></name>, <name><surname>Turkbey</surname><given-names>EB</given-names></name>, <name><surname>Williams</surname><given-names>R</given-names></name>, <etal>et al</etal><article-title>Normal values for cardiovascular magnetic resonance in adults and children</article-title>. <source>J Cardiovasc Magn Reson</source>. <year>2015</year>;<volume>17</volume>: <fpage>29</fpage><pub-id pub-id-type="doi">10.1186/s12968-015-0111-7</pub-id><?supplied-pmid 25928314?><pub-id pub-id-type="pmid">25928314</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Afonso</surname><given-names>LC</given-names></name>, <name><surname>Bernal</surname><given-names>J</given-names></name>, <name><surname>Bax</surname><given-names>JJ</given-names></name>, <name><surname>Abraham</surname><given-names>TP</given-names></name>. <article-title>Echocardiography in hypertrophic cardiomyopathy. The role of conventional and emerging technologies</article-title>. <source>JACC Cardiovasc Imaging</source>. <year>2008</year>;<volume>1</volume>: <fpage>787</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmg.2008.09.002</pub-id>
<?supplied-pmid 19356516?><pub-id pub-id-type="pmid">19356516</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Maron</surname><given-names>MS</given-names></name>. <article-title>Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy</article-title>. <source>J Cardiovasc Magn Reson</source>. <year>2012</year>;<volume>14</volume>: <fpage>13</fpage><pub-id pub-id-type="doi">10.1186/1532-429X-14-13</pub-id><?supplied-pmid 22296938?><pub-id pub-id-type="pmid">22296938</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Fahmy</surname><given-names>AS</given-names></name>, <name><surname>Rausch</surname><given-names>J</given-names></name>, <name><surname>Neisius</surname><given-names>U</given-names></name>, <name><surname>Chan</surname><given-names>RH</given-names></name>, <name><surname>Maron</surname><given-names>MS</given-names></name>, <name><surname>Appelbaum</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Automated cardiac MR scar quantification in hypertrophic cardiomyopathy using deep convolutional neural networks</article-title>. <source>JACC Cardiovasc Imaging</source>. <year>2018</year>;<volume>11</volume>: <fpage>1917</fpage>–<lpage>1918</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmg.2018.04.030</pub-id>
<?supplied-pmid 30121270?><pub-id pub-id-type="pmid">30121270</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>RH</given-names></name>, <name><surname>Maron</surname><given-names>BJ</given-names></name>, <name><surname>Olivotto</surname><given-names>I</given-names></name>, <name><surname>Pencina</surname><given-names>MJ</given-names></name>, <name><surname>Assenza</surname><given-names>GE</given-names></name>, <name><surname>Haas</surname><given-names>T</given-names></name>, <etal>et al</etal><article-title>Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy</article-title>. <source>Circulation</source>. <year>2014</year>;<volume>130</volume>: <fpage>484</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.007094</pub-id>
<?supplied-pmid 25092278?><pub-id pub-id-type="pmid">25092278</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Weingärtner</surname><given-names>S</given-names></name>, <name><surname>Roujol</surname><given-names>S</given-names></name>, <name><surname>Akçakaya</surname><given-names>M</given-names></name>, <name><surname>Basha</surname><given-names>TA</given-names></name>, <name><surname>Nezafat</surname><given-names>R</given-names></name>. <article-title>Free-breathing multislice native myocardial T<sub>1</sub> mapping using the slice-interleaved T<sub>1</sub> (STONE) sequence</article-title>. <source>Magn Reson Med</source>. <year>2015</year>;<volume>74</volume>: <fpage>115</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.25387</pub-id>
<?supplied-pmid 25131652?><pub-id pub-id-type="pmid">25131652</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Roujol</surname><given-names>S</given-names></name>, <name><surname>Foppa</surname><given-names>M</given-names></name>, <name><surname>Weingärtner</surname><given-names>S</given-names></name>, <name><surname>Manning</surname><given-names>WJ</given-names></name>, <name><surname>Nezafat</surname><given-names>R</given-names></name>. <article-title>Adaptive registration of varying contrast-weighted images for improved tissue characterization (ARCTIC): Application to T1 mapping</article-title>. <source>Magn Reson Med</source>. <year>2015</year>;<volume>73</volume>: <fpage>1469</fpage>–<lpage>1482</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.25270</pub-id>
<?supplied-pmid 24798588?><pub-id pub-id-type="pmid">24798588</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Lang</surname><given-names>RM</given-names></name>, <name><surname>Badano</surname><given-names>LP</given-names></name>, <name><surname>Mor-Avi</surname><given-names>V</given-names></name>, <name><surname>Afilalo</surname><given-names>J</given-names></name>, <name><surname>Armstrong</surname><given-names>A</given-names></name>, <name><surname>Ernande</surname><given-names>L</given-names></name>, <etal>et al</etal><article-title>Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging</article-title>. <source>J Am Soc Echocardiogr</source>. <year>2015</year>;<volume>28</volume>: <fpage>1</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.echo.2014.10.003</pub-id>
<?supplied-pmid 25559473?><pub-id pub-id-type="pmid">25559473</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Salerno</surname><given-names>M.</given-names></name><article-title>Feature Tracking by CMR</article-title>. <source>JACC Cardiovasc Imaging</source>. <year>2017</year>;<volume>11</volume>: <fpage>206</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmg.2017.01.024</pub-id>
<?supplied-pmid 28528158?><pub-id pub-id-type="pmid">28528158</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Rodrigues</surname><given-names>JCL</given-names></name>, <name><surname>Rohan</surname><given-names>S</given-names></name>, <name><surname>Ghosh Dastidar</surname><given-names>A</given-names></name>, <name><surname>Harries</surname><given-names>I</given-names></name>, <name><surname>Lawton</surname><given-names>CB</given-names></name>, <name><surname>Ratcliffe</surname><given-names>LE</given-names></name>, <etal>et al</etal><article-title>Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm</article-title>. <source>Eur Radiol</source>. <year>2017</year>;<volume>27</volume>: <fpage>1125</fpage>–<lpage>1135</lpage>. <pub-id pub-id-type="doi">10.1007/s00330-016-4468-2</pub-id>
<?supplied-pmid 27368925?><pub-id pub-id-type="pmid">27368925</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Narayanan</surname><given-names>A</given-names></name>, <name><surname>Aurigemma</surname><given-names>GP</given-names></name>, <name><surname>Chinali</surname><given-names>M</given-names></name>, <name><surname>Hill</surname><given-names>JC</given-names></name>, <name><surname>Meyer</surname><given-names>TE</given-names></name>, <name><surname>Tighe</surname><given-names>DA</given-names></name>. <article-title>Cardiac mechanics in mild hypertensive heart disease: A speckle-strain imaging study</article-title>. <source>Circ Cardiovasc Imaging</source>. <year>2009</year>;<volume>2</volume>: <fpage>382</fpage>–<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCIMAGING.108.811620</pub-id>
<?supplied-pmid 19808626?><pub-id pub-id-type="pmid">19808626</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Vigneault</surname><given-names>DM</given-names></name>, <name><surname>Yang</surname><given-names>DE</given-names></name>, <name><surname>Jensen</surname><given-names>PJ</given-names></name>, <name><surname>Tee</surname><given-names>BSMW</given-names></name>, <name><surname>Colan</surname><given-names>SD</given-names></name>, <name><surname>Russell</surname><given-names>MW</given-names></name>, <etal>et al</etal><article-title>Left ventricular strain is abnormal in preclinical and overt hypertrophic cardiomyopathy: Cardiac MR feature tracking</article-title>. <source>Radiology</source>. <year>2019</year>;<volume>00</volume>: <fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0221061.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Aletras</surname><given-names>AH</given-names></name>, <name><surname>Tilak</surname><given-names>GS</given-names></name>, <name><surname>Hsu</surname><given-names>LY</given-names></name>, <name><surname>Arai</surname><given-names>AE</given-names></name>. <article-title>Heterogeneity of intramural function in hypertrophic cardiomyopathy mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps</article-title>. <source>Circ Cardiovasc Imaging</source>. <year>2011</year>;<volume>4</volume>: <fpage>425</fpage>–<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCIMAGING.110.958751</pub-id>
<?supplied-pmid 21576279?><pub-id pub-id-type="pmid">21576279</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Haland</surname><given-names>TF</given-names></name>, <name><surname>Almaas</surname><given-names>VM</given-names></name>, <name><surname>Hasselberg</surname><given-names>NE</given-names></name>, <name><surname>Saberniak</surname><given-names>J</given-names></name>, <name><surname>Leren</surname><given-names>IS</given-names></name>, <name><surname>Hopp</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy</article-title>. <source>Eur Heart J Cardiovasc Imaging</source>. <year>2016</year>;<volume>17</volume>: <fpage>613</fpage>–<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jew005</pub-id>
<?supplied-pmid 26873460?><pub-id pub-id-type="pmid">26873460</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Hinojar</surname><given-names>R</given-names></name>, <name><surname>Fernández-Golfín</surname><given-names>C</given-names></name>, <name><surname>González-Gómez</surname><given-names>A</given-names></name>, <name><surname>Rincón</surname><given-names>LM</given-names></name>, <name><surname>Plaza-Martin</surname><given-names>M</given-names></name>, <name><surname>Casas</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis</article-title>. <source>Int J Cardiol</source>. <year>2017</year>;<volume>249</volume>: <fpage>467</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2017.07.087</pub-id>
<?supplied-pmid 29121751?><pub-id pub-id-type="pmid">29121751</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Saito</surname><given-names>M</given-names></name>, <name><surname>Okayama</surname><given-names>H</given-names></name>, <name><surname>Yoshii</surname><given-names>T</given-names></name>, <name><surname>Higashi</surname><given-names>H</given-names></name>, <name><surname>Morioka</surname><given-names>H</given-names></name>, <name><surname>Hiasa</surname><given-names>G</given-names></name>, <etal>et al</etal><article-title>Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy</article-title>. <source>Eur Hear J—Cardiovasc Imaging</source>. <year>2012</year>;<volume>13</volume>: <fpage>617</fpage>–<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1093/ejechocard/jer318</pub-id>
<?supplied-pmid 22271116?><pub-id pub-id-type="pmid">22271116</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>JM</given-names></name>, <name><surname>Liu</surname><given-names>A</given-names></name>, <name><surname>Leal</surname><given-names>J</given-names></name>, <name><surname>McMillan</surname><given-names>F</given-names></name>, <name><surname>Francis</surname><given-names>J</given-names></name>, <name><surname>Greiser</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Measurement of myocardial native T<sub>1</sub> in cardiovascular diseases and norm in 1291 subjects</article-title>. <source>J Cardiovasc Magn Reson</source>. <year>2017</year>;<volume>19</volume>: <fpage>74</fpage><pub-id pub-id-type="doi">10.1186/s12968-017-0386-y</pub-id><?supplied-pmid 28954631?><pub-id pub-id-type="pmid">28954631</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Rudolph</surname><given-names>A</given-names></name>, <name><surname>Abdel-Aty</surname><given-names>H</given-names></name>, <name><surname>Bohl</surname><given-names>S</given-names></name>, <name><surname>Boyé</surname><given-names>P</given-names></name>, <name><surname>Zagrosek</surname><given-names>A</given-names></name>, <name><surname>Dietz</surname><given-names>R</given-names></name>, <etal>et al</etal><article-title>Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy. Relation to remodeling</article-title>. <source>J Am Coll Cardiol</source>. <year>2009</year>;<volume>53</volume>: <fpage>284</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2008.08.064</pub-id>
<?supplied-pmid 19147047?><pub-id pub-id-type="pmid">19147047</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Puntmann</surname><given-names>VO</given-names></name>, <name><surname>Jahnke</surname><given-names>C</given-names></name>, <name><surname>Gebker</surname><given-names>R</given-names></name>, <name><surname>Schnackenburg</surname><given-names>B</given-names></name>, <name><surname>Fox</surname><given-names>KF</given-names></name>, <name><surname>Fleck</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy</article-title>. <source>Am J Cardiol</source>. <year>2010</year>;<volume>106</volume>: <fpage>1016</fpage>–<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2010.05.036</pub-id>
<?supplied-pmid 20854967?><pub-id pub-id-type="pmid">20854967</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Canepa</surname><given-names>M</given-names></name>, <name><surname>Pozios</surname><given-names>I</given-names></name>, <name><surname>Vianello</surname><given-names>PF</given-names></name>, <name><surname>Ameri</surname><given-names>P</given-names></name>, <name><surname>Brunelli</surname><given-names>C</given-names></name>, <name><surname>Ferrucci</surname><given-names>L</given-names></name>, <etal>et al</etal><article-title>Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly</article-title>. <source>Heart</source>. <year>2016</year>;<volume>102</volume>: <fpage>1087</fpage>–<lpage>1094</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2015-308764</pub-id>
<?supplied-pmid 27122487?><pub-id pub-id-type="pmid">27122487</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref051">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Goebel</surname><given-names>J</given-names></name>, <name><surname>Seifert</surname><given-names>I</given-names></name>, <name><surname>Nensa</surname><given-names>F</given-names></name>, <name><surname>Schemuth</surname><given-names>HP</given-names></name>, <name><surname>Maderwald</surname><given-names>S</given-names></name>, <name><surname>Quick</surname><given-names>HH</given-names></name>, <etal>et al</etal><article-title>Can native T<sub>1</sub> mapping differentiate between healthy and diffuse diseased myocardium in clinical routine cardiac MR imaging?</article-title><source>PLoS One</source>. <year>2016</year>;<volume>11</volume>: <fpage>e0155591</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0155591</pub-id><?supplied-pmid 27219329?><pub-id pub-id-type="pmid">27219329</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref052">
                <label>52</label>
                <mixed-citation publication-type="journal"><name><surname>Kato</surname><given-names>S</given-names></name>, <name><surname>Nakamori</surname><given-names>S</given-names></name>, <name><surname>Bellm</surname><given-names>S</given-names></name>, <name><surname>Jang</surname><given-names>J</given-names></name>, <name><surname>Basha</surname><given-names>T</given-names></name>, <name><surname>Maron</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Myocardial native T<sub>1</sub> time in patients with hypertrophic cardiomyopathy</article-title>. <source>Am J Cardiol</source>. <year>2016</year>;<volume>118</volume>: <fpage>1057</fpage>–<lpage>1062</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2016.07.010</pub-id>
<?supplied-pmid 27567135?><pub-id pub-id-type="pmid">27567135</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref053">
                <label>53</label>
                <mixed-citation publication-type="journal"><name><surname>Child</surname><given-names>N</given-names></name>, <name><surname>Suna</surname><given-names>G</given-names></name>, <name><surname>Dabir</surname><given-names>D</given-names></name>, <name><surname>Yap</surname><given-names>M-L</given-names></name>, <name><surname>Rogers</surname><given-names>T</given-names></name>, <name><surname>Kathirgamanathan</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction</article-title>. <source>Eur Hear J—Cardiovasc Imaging</source>. <year>2017</year>; <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jex309</pub-id>
<?supplied-pmid 29237044?><pub-id pub-id-type="pmid">29237044</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0221061.ref054">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Nielles-Vallespin</surname><given-names>S</given-names></name>, <name><surname>Khalique</surname><given-names>Z</given-names></name>, <name><surname>Ferreira</surname><given-names>PF</given-names></name>, <name><surname>de Silva</surname><given-names>R</given-names></name>, <name><surname>Scott</surname><given-names>AD</given-names></name>, <name><surname>Kilner</surname><given-names>P</given-names></name>, <etal>et al</etal><article-title>Assessment of myocardial microstructural dynamics by in vivo diffusion tensor cardiac magnetic resonance</article-title>. <source>J Am Coll Cardiol</source>. <year>2017</year>;<volume>69</volume>: <fpage>661</fpage>–<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2016.11.051</pub-id>
<?supplied-pmid 28183509?><pub-id pub-id-type="pmid">28183509</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
